Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 946889 | IM / RA |
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | F4AC3 | IM / RA |
Vaccine was administered outside of ACIP guidelines. (Patient received 1st dose 1/14/25)
None
NKDA